October 18, 2019 / 11:20 AM / a month ago

Merck gets EU panel nod for first ever Ebola vaccine

Oct 18 (Reuters) - A panel of the European drugs regulator on Friday recommended approving Merck & Co's vaccine for the deadly Ebola virus.

The European Medicines Agency said bit.ly/2MrRw4c its human medicines committee (CHMP) has recommended granting a conditional marketing authorisation in the European Union for the vaccine, Ervebo, for individuals aged 18 years and older. (Reporting by Pushkala Aripaka in Bengaluru Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below